Overall, CaMKII activity and enhanced necroptosis in cardiac hypertrophy are dependent on RIPK3; the RIPK3 inhibitor GSK'872 had a significant protective effect on AMP-AngII-induced cardiac hypertrophy in WT mice. The gene discussed is CAMK2G; the disease is cardiac hypertrophy.